Combination of Essential Oil of Melaleuca alternifolia and Iodine in the Treatment of Molluscum Contagiosum in Children

25. Carson CF, Riley TV. Susceptibility of propionibacterium acnes to the essential oil of Melaleuca alternifolia. Lett Appl Micro. 1994;19:24-25.
26. Carson CF, Riley TV. The antimicrobial activity of tea tree oil. Med J Austr. 1994;160:236-239.
27. Carson CF, Cookson BD, Farrelly HD, Riley TV. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother. 1995;35:421-424.
28. Carson CF, Hammer KA, Riley TV. Broth micro-dilution method for determining the susceptibility of Eschericha. coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia. Microbios. 1995;82:181-185.
29. Elsom G. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother. 1999;43:427-428.
30. Belaiche P. Treatment of skin and nail infections with the essential oil of Melaleuca alternifolia-Cheel. Phytother. 1985;15:15-18.
31. Hammer KA, Carson CF, Riley TV. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Inf Control. 1996;243:186-189.
32. Nakamura J, Muraki Y, Yamada M, Hatano Y, Nii S. Analysis of molluscum contagiosum virus genomes isolated in Japan. J Med Virol. 1995;46:339-48.
33. Porter CD, Archard LC. Characterization by restriction mapping of subtypes of moll cont virus. J Med Virol. 1992;38:1-5.
34. Odom RB, James WD, Berger TG. Andrews' Diseases of the Skin: Clinical Dermatology. 9th ed. Philadelphia: WB Saunders Company. 2000;501-503.
35. Wutzler P, Sauerbrei A, Klocking R, Brogmann B, Reimer K. Virucidal activity and cytotoxicity of the liposomal formulation of providone-iodine. Antiviral Res. 2002;54:89-97.
36. Murray PR. Medical Microbiology 4th ed. St Louis, MO: Mosby. 2005;381-383.
37. Reynolds JEF ed. (1989) Martindale, the extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press. 1989;1184-1186.
38. Dela Cruz F, Brown DH, Leiken JB. Iodine absorption after topical administration. West J Med. 1987;146:43-45.
39. Centers for Disease Control recommendations available at http://www.cdc.gov/ncidod/dvrd/molluscum/swimming/swimming_recommendations.htm.
40. Hammer KA, Carson CF, Riley TV, Neilsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol. 2006;44:616-625.
41. Fritz TM, Burg G, Krasovec M. Allergic contact dermatitis in cosmetics containing Melaleuca alternifolia (tea tree oil). Ann Dermatol Venereol. 2001;128:123-126.
42. Hausen BM, Reichling J, Harkenthal M. Degradation products of monoterpens are the sensitizing agents in tea tree oil. Am J. Contact Dermat. 1999;10:68-77.
43. Schnitzler P, Schon K, Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie. 2001;56:343-347.
44. Astani A, Reichling J, Schnitzler P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother Res. 2010;24:673-679.
45. Millar BC, Moore JE. Successful topical treatment of hand warts in a paediatric patient with tea tree oil. Complement Ther Clin Pract. 2008;14:225-227.
46. Murray KE. The essential oils of 5 western Australian plants. Royal Australian Chemical Institute and Proceedings. 1950;17:398-410.
47. Hammer KA, Carson CF, Riley TV, Neilsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol. 2006;44:616-625.
48. Cross SE, Russell M, Southwell I, Roberts MS. Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro. Eur J Pharm Biopharm. 2008;69;214-222.
49. Reichling J, Landvatter U, Wagner H, Kostka KH, Schaefer UF. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations. Eur J Pharm Biopharm. 2006;64:222-228.

Address for Correspondence